TT virus infections among blood donors in Iceland:: prevalence, genotypes, and lack of relationship to serum ALT levels

被引:8
作者
Löve, A
Stanzeit, B
Li, L
Olafsdóttir, E
Gudmundsson, S
Briem, H
Widell, A
机构
[1] Natl Univ Hosp Reykjavik, Dept Med Virol, IS-128 Reykjavik, Iceland
[2] Natl Univ Hosp Reykjavik, Blood Bank, IS-128 Reykjavik, Iceland
[3] Natl Univ Hosp Reykjavik, Dept Clin Biochem, IS-128 Reykjavik, Iceland
[4] Directorate Publ Hlth, Div Infect Dis Control, Reykjavik, Iceland
[5] Lund Univ, Malmo Univ Hosp, Dept Microbiol, Malmo, Sweden
关键词
D O I
10.1046/j.1537-2995.2000.40030306.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The TT virus (TTV) is a newly identified blood-borne virus. Its association with disease is still unknown, and screening of blood donors has not been implemented. Several genotypes of the TTV have been identified. STUDY DESIGN AND METHODS: Three hundred seventy healthy blood donors were randomly selected and tested for TTV by the PCR method. Sequencing of a part of the genome was performed to identify various genotypes of the virus. ALT levels were determined in both infected and uninfected individuals. RESULTS: The TT virus (TTV), was detected in the sera of 23 (6.2%) of 370 healthy Icelandic blood donors; this prevalence is lower than that reported in Japan but higher than that in Scotland. The virus was found in all groups over the age of 19. Sequencing and phylogenetic analysis of 202 bp from open reading frame 1 demonstrated genotypes 1b and 2b 2c and genotype 4 isolates, with the latter bearing 89-percent nucleotide homology with other genotype 4 sequences deposited at GenBank. One sample showed a mixed genotype 1b/ 2c infection. Serum ALT levels were within normal limits in all infected individuals. CONCLUSION: The TTV carrier state does not cause significant liver injury.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 11 条
[1]  
[Anonymous], 1994, EPI INFO VERSION 6 W
[2]   Hepatitis C virus and GB virus C hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels [J].
Björkman, P ;
Sundström, G ;
Widell, A .
TRANSFUSION, 1998, 38 (04) :378-384
[3]   TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis [J].
Charlton, M ;
Adjei, P ;
Poterucha, J ;
Zein, N ;
Moore, B ;
Therneau, T ;
Krom, R ;
Wiesner, R .
HEPATOLOGY, 1998, 28 (03) :839-842
[4]   TTV a common virus, but pathogenic? [J].
Cossart, Y .
LANCET, 1998, 352 (9123) :164-164
[5]   HEPATITIS-C VIRUS-INFECTION IN ICELAND - A RECENTLY INTRODUCED BLOOD-BORNE DISEASE [J].
LOVE, A ;
STANZEIT, B .
EPIDEMIOLOGY AND INFECTION, 1994, 113 (03) :529-536
[6]   Hepatitis G virus infections in Iceland [J].
Löve, A ;
Stanzeit, B ;
Gudmundsson, S ;
Widell, A .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (03) :255-260
[7]   Presence of a newly described human DNA virus (TTV) in patients with liver disease [J].
Naoumov, NV ;
Petrova, EP ;
Thomas, MG ;
Williams, R .
LANCET, 1998, 352 (9123) :195-197
[8]   A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology [J].
Nishizawa, T ;
Okamoto, H ;
Konishi, K ;
Yoshizawa, H ;
Miyakawa, Y ;
Mayumi, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (01) :92-97
[9]   Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology [J].
Okamoto, H ;
Nishizawa, T ;
Kato, N ;
Ukita, M ;
Ikeda, H ;
Iizuka, H ;
Miyakawa, Y ;
Mayumi, M .
HEPATOLOGY RESEARCH, 1998, 10 (01) :1-16
[10]  
Simmonds P, 1998, LANCET, V352, P1394